Carbon capture and storage (CCS) can help nations meet their Paris CO reduction commitments cost-effectively. However, lack of confidence in geologic CO storage security remains a barrier to CCS implementation. Here we present a numerical program that calculates CO storage security and leakage to the atmosphere over 10,000 years. This combines quantitative estimates of geological subsurface CO retention, and of surface CO leakage. We calculate that realistically well-regulated storage in regions with moderate well densities has a 50% probability that leakage remains below 0.0008% per year, with over 98% of the injected CO retained in the subsurface over 10,000 years. An unrealistic scenario, where CO storage is inadequately regulated, estimates that more than 78% will be retained over 10,000 years. Our modelling results suggest that geological storage of CO can be a secure climate change mitigation option, but we note that long-term behaviour of CO in the subsurface remains a key uncertainty.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997736PMC
http://dx.doi.org/10.1038/s41467-018-04423-1DOI Listing

Publication Analysis

Top Keywords

storage security
12
10000 years
12
geological storage
8
storage
7
estimating geological
4
security deliver
4
deliver climate
4
climate mitigation
4
mitigation carbon
4
carbon capture
4

Similar Publications

Objective: This study examined the longitudinal development of metacognitive skills and clinical decision-making abilities in nursing students, focusing on the interactions between metacognitive processes, situational factors, and individual differences.

Methods: A longitudinal, quantitative design was employed, following 185 third-year nursing students from a major university in China over one academic year. Data were collected at six time points using the Metacognitive Awareness Inventory, Nursing Decision-Making Instrument, and custom-designed clinical scenario assessments.

View Article and Find Full Text PDF

An open-source SQL database schema for integrated clinical and translational data management in clinical trials.

Clin Trials

December 2024

Cancer Research UK Southampton Clinical Trials Unit, MP131, Southampton General Hospital, University of Southampton, Southampton, UK.

Unlocking the power of personalised medicine in oncology hinges on the integration of clinical trial data with translational data (i.e. biospecimen-derived molecular information).

View Article and Find Full Text PDF

Electronic health records are one of the essential components of health organizations. In recent years, there have been increased concerns about privacy and reputation regarding the storage and use of patient information. In this regard, the information provided as a part of medical and health insurance, for instance, can be viewed as proof of social insurance and governance.

View Article and Find Full Text PDF

Renewable energy transition in Europe in the context of renewable energy transition processes in the world. A review.

Heliyon

December 2024

GPCHEM, Laboratory of Biogas Research and Analysis & Technology Incubator, Ul. Legionów 40a/3, 87-100 Toruń, Poland.

Both the global and European energy sectors have been undergoing a deep transition for several years, associated with a reduction in the overall share of conventional coal-based energy in favor of new technologies, especially energy from renewable sources (RES). This transition is moving from centralized production towards distributed technologies and from providing only energy to end users towards combining innovative products and services with it. Electricity consumers are becoming prosumers connected to the grid and generating an increasing amount of energy.

View Article and Find Full Text PDF

Background: The combination of high prices and uncertain effectiveness is a growing challenge in the field of orphan medicines, hampering health technology assessments. Hence, new methods for establishing price benchmarks might be necessary to support reimbursement negotiations. In this study, we applied several pricing models containing cost-based elements to the case of lumasiran for treating primary hyperoxaluria type 1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!